Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
What factors should be considered when prescribing anticoagulants for patients with scleroderma-associated vasculopathy, and how does therapy influence vascular complications and overall disease progression?
